Menu
Search
|

Menu

Close
X

Meridian Bioscience Inc VIVO.OQ (NASDAQ Stock Exchange Global Select Market)

16.75 USD
+0.00 (+0.00%)
As of Jun 22
chart
Previous Close 16.75
Open 16.85
Volume 280,664
3m Avg Volume 71,577
Today’s High 17.05
Today’s Low 16.65
52 Week High 17.05
52 Week Low 13.35
Shares Outstanding (mil) 42.34
Market Capitalization (mil) 709.27
Forward P/E 42.76
Dividend (Yield %) 0.12 ( 2.99 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
3.20 Mean rating from 5 analysts

KEY STATS

Revenue (mm, USD)
FY18
109
FY17
201
FY16
196
FY15
195
EPS (USD)
FY18
0.252
FY17
0.506
FY16
0.760
FY15
0.845
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
42.76
34.14
Price to Sales (TTM)
vs sector
3.40
8.17
Price to Book (MRQ)
vs sector
4.07
4.30
Price to Cash Flow (TTM)
vs sector
28.49
22.70
Total Debt to Equity (MRQ)
vs sector
30.06
17.55
LT Debt to Equity (MRQ)
vs sector
27.48
13.12
Return on Investment (TTM)
vs sector
7.26
13.10
Return on Equity (TTM)
vs sector
9.69
15.09

EXECUTIVE LEADERSHIP

John Kraeutler
Executive Chairman of the Board, Since 2017
Salary: $655,942.00
Bonus: --
John Kenny
Chief Executive Officer, Director, Since 2017
Salary: --
Bonus: --
Melissa Lueke
Chief Financial Officer, Executive Vice President, Secretary, Since 2009
Salary: $339,520.00
Bonus: --
Marco Calzavara
President and Managing Director of Meridian Bioscience Europe, Since 2011
Salary: $324,503.00
Bonus: --
Lawrence Baldini
Executive Vice President and President - Global Operations, Since 2016
Salary: $310,001.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

3471 River Hills Dr
CINCINNATI   OH   45244

Phone: +1513.2713700

Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers. Its segments include Diagnostics and Life Science. The Diagnostics segment includes manufacturing operations in Cincinnati, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America; Europe, the Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia.

SPONSORED STORIES